The Health Ministry’s Department for Science, Technology and Training said on July 27, one of the three was sealed between two Vietnamese companies - the Company for Vaccine and Biological Production No.1 (VABIOTECH) and the International Progressive Joint Stock Company - and Japanese pharmaceutical firm Shionogi.
The second contract involving Russian Sputnik V vaccine was inked between VABIOTECH, DS-Bio, and the Russian Direct Investment Fund, with the Vietnamese side being in charge of packaging the vaccine tubes from the semi-finished products.
For technology transfer projects with US partners, the Ministry of Health has sent a group of experts to coordinate with the World Health Organization to support relevant units in completing dossiers for clinical trials phase 1-2-3 according to a shortened process, with the research expected to start on August 1 and end in late December.
The transfer and the building of a vaccine factory in Viet♊nam will b🔯e completed in June 2022./.
